Clinical Trials Browser

Breast Neoplasms × Bortezomib × 1 year × Clear all

NCT04265872 2026-02-12

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms